多学科瘤委员会中的人工智能增强了瘤学的决策和临床结果
Xiaodong Wang1, Qianqian Wang2, Gouping Ding1
1Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
iScience
|December 24, 2025
概括
人工智能 (AI) 通过改善信息合成和决策一致性来增强多学科瘤委员会 (MDTs),据报道,AI和MDT决策之间的一致性从70%到90%不等. 虽然人工智能提供了好处,但仔细实施和验证对于其有效地融入癌症治疗至关重要.
科学领域:
- 在瘤学瘤学.
- 医疗信息学 医疗信息学
- 人工智能在医学中的应用
背景情况:
- 多学科瘤委员会 (MDTs) 对于协调复杂的癌症护理决策至关重要.
- 多样化的数据 (成像,病理学,基因组学,患者因素) 的整合对MDT来说是一个重大挑战.
- 人工智能 (AI) 技术为优化MDT流程提供了潜在的解决方案.
研究的目的:
- 综合人工智能的当前应用,以支持MDT的准备和审议.
- 在MDTs的背景下评估AI工具的性能,好处和局限性.
- 概述AI在MDT工作流程中有效实施的优先事项.
主要方法:
- 对MDTs中的AI应用现有文献进行系统审查和综合.
- 分析AI在MDT决策的各个阶段的作用,包括准备和审议.
- 人工智能技术的分类,包括机器学习,自然语言处理,深度学习和大型语言模型.
主要成果:
- 人工智能工具在癌症查和分期方面表现出高的诊断性能.
- 在各种癌症中,AI建议和MDT决定之间报告的一致性从70%到90%不等.
- 关键的好处包括加快信息合成,改善准则的遵守,提高文档清晰度.
结论:
- 人工智能显示出增强MDT决策,个性化患者护理和提高工作流程效率的巨大潜力.
- 诸如数据偏差,概括性问题,隐私问题和不足的验证等局限性需要仔细考虑.
- 人工智能实施的优先事项包括未来的多中心评估,EHR集成,临床医师培训和强有力的监督.
更多相关视频
10:25Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning
Published on: April 12, 2024
2.2K
09:53Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
7.6K
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
